Clinical Trial Update: A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan plus cetuximab with or without enzastaurin in colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Enzastaurin (enzastaurin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer, Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-07-21